paclitaxel has been researched along with Nephrosis, Lipoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, S; Ichita, C; Kako, M; Kimura, K; Koizumi, K; Kudo, M; Masuda, S; Moriya, H; Nishino, T; Sasaki, A; Tasaki, J; Tazawa, T; Uojima, H | 1 |
| Fukui, A; Haruhara, K; Kawamura, T; Koike, K; Miyazaki, Y; Nakao, M; Ogura, M; Tsuboi, N; Yokoo, T | 1 |
| Inoue, T; Maeda, Y; Maniwa, K; Minakuchi, M; Miyajima, S; Okamoto, M; Sakuramoto, M; Taguchi, Y; Takeda, T; Tanaka, E; Tanizawa, K | 1 |
3 other study(ies) available for paclitaxel and Nephrosis, Lipoid
| Article | Year |
|---|---|
Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
Topics: Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Humans; Male; Nephrosis, Lipoid; Paclitaxel; Pancreatic Neoplasms | 2021 |
[A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab].
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Female; Humans; Nephrosis, Lipoid; Paclitaxel; Vascular Endothelial Growth Factors | 2014 |
[A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia].
Topics: Adenocarcinoma; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Brain Neoplasms; Carboplatin; Cranial Irradiation; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Nephrosis, Lipoid; Paclitaxel; Prednisolone | 2006 |